Literature DB >> 27003951

Efficient Syntheses of Vitamin K Chain-Shortened Acid Metabolites.

Aaron M Teitelbaum1, Michele Scian1, Wendel L Nelson1, Allan E Rettie1.   

Abstract

Vitamin K sequentially undergoes ω-oxidation followed by successive rounds of β-oxidation to ultimately produce two chain-shortened carboxylic acid metabolites, vitamin K acid 1 and vitamin K acid 2. Two facile syntheses of these acid metabolites are described, each starting from commercially available menadione-cyclopentadiene adduct 3. Vitamin K acid 1 was synthesized in five steps via alkylation with a geranyl halide followed by subsequent oxidation reactions, while fully retaining the trans configuration of the side chain 2',3'-double bond. Vitamin K acid 2 was synthesized in 5 steps from 3via alkylation with dimethylallyl chloride and subsequent oxidation reactions.

Entities:  

Year:  2015        PMID: 27003951      PMCID: PMC4798747          DOI: 10.1055/s-0034-1380002

Source DB:  PubMed          Journal:  Synthesis (Stuttg)        ISSN: 0039-7881            Impact factor:   3.157


  12 in total

1.  Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection.

Authors:  Dominic J Harrington; Robin Soper; Christine Edwards; Geoffrey F Savidge; Stephen J Hodges; Martin J Shearer
Journal:  J Lipid Res       Date:  2005-02-01       Impact factor: 5.922

2.  Design and synthesis of biologically active analogues of vitamin K2: evaluation of their biological activities with cultured human cell lines.

Authors:  Yoshitomo Suhara; Yoshihisa Hirota; Kimie Nakagawa; Maya Kamao; Naoko Tsugawa; Toshio Okano
Journal:  Bioorg Med Chem       Date:  2008-01-02       Impact factor: 3.641

Review 3.  Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.

Authors:  Sarah Cockayne; Joy Adamson; Susan Lanham-New; Martin J Shearer; Simon Gilbody; David J Torgerson
Journal:  Arch Intern Med       Date:  2006-06-26

4.  Ubiquinone and related compounds. XXVII. Synthesis of urinary metabolites of phylloquinone and alpha-tocopherol.

Authors:  M Watanabe; M Kawada; M Nishikawa; I Imada; H Morimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1974-03       Impact factor: 1.645

5.  Studies on the metabolites of phylloquinone (vitamin K 1 ) in the urine of man.

Authors:  M J Shearer; P Barkhan
Journal:  Biochim Biophys Acta       Date:  1973-02-28

6.  Ruthenium-catalyzed reduction of allylic alcohols: an efficient isomerization/transfer hydrogenation tandem process.

Authors:  Victorio Cadierno; Javier Francos; José Gimeno; Noel Nebra
Journal:  Chem Commun (Camb)       Date:  2007-03-19       Impact factor: 6.222

7.  High dietary menaquinone intake is associated with reduced coronary calcification.

Authors:  Joline W J Beulens; Michiel L Bots; Femke Atsma; Marie-Louise E L Bartelink; Matthias Prokop; Johanna M Geleijnse; Jacqueline C M Witteman; Diederick E Grobbee; Yvonne T van der Schouw
Journal:  Atherosclerosis       Date:  2008-07-19       Impact factor: 5.162

8.  Preparative isolation and characterization of the urinary aglycones of vitamin K1 (phylloquinone in man.

Authors:  A McBurney; M J Shearer; P Barkhan
Journal:  Biochem Med       Date:  1980-12

9.  Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency.

Authors:  Melissa Vos; Giovanni Esposito; Janaka N Edirisinghe; Sven Vilain; Dominik M Haddad; Jan R Slabbaert; Stefanie Van Meensel; Onno Schaap; Bart De Strooper; R Meganathan; Vanessa A Morais; Patrik Verstreken
Journal:  Science       Date:  2012-05-10       Impact factor: 47.728

10.  Facile oxidation of aldehydes to acids and esters with Oxone.

Authors:  Benjamin R Travis; Meenakshi Sivakumar; G Olatunji Hollist; Babak Borhan
Journal:  Org Lett       Date:  2003-04-03       Impact factor: 6.005

View more
  1 in total

1.  A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine.

Authors:  Matthew G McDonald; Catherine K Yeung; Aaron M Teitelbaum; Amanda L Johnson; Shinya Fujii; Hiroyuki Kagechika; Allan E Rettie
Journal:  J Lipid Res       Date:  2019-01-22       Impact factor: 5.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.